SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

Company logo. images.investorshub.advfn.com/images/uploads/2012/5/17/rtkhgrxii.jpg

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
PoemStone Member Profile
 
Followed By 857
Posts 27,878
Boards Moderated 1
Alias Born 11/05/10
160x600 placeholder
RXi Pharmaceuticals to Present at the 2017 Annual BIO Investor Forum "PR Newswire (US)" - 10/11/2017 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 3:46:00 PM
RXi Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference "PR Newswire (US)" - 9/19/2017 7:05:00 AM
RXi Pharmaceuticals to Present at BioPharm America's 10th Annual International Partnering Conference "PR Newswire (US)" - 9/18/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/15/2017 4:32:24 PM
RXi Pharmaceuticals Announces the Departure of Dr. Alexey Eliseev as Chief Business Officer "PR Newswire (US)" - 9/15/2017 4:30:00 PM
BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA®) for the Treatment of... "PR Newswire (US)" - 9/15/2017 7:05:00 AM
RXi Pharmaceuticals Announces Completion of Enrollment of Phase 2 Clinical Trial with Samcyprone for Cutaneous Warts "PR Newswire (US)" - 9/6/2017 7:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 8/31/2017 4:32:56 PM
RXi Pharmaceuticals Corporation Selected to Present at the 8th Annual Investing for Cures Forum "PR Newswire (US)" - 8/31/2017 7:05:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 8/31/2017 6:02:23 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/24/2017 11:56:48 AM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 8/18/2017 5:24:07 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 8/18/2017 5:19:08 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/10/2017 7:17:15 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/10/2017 7:08:44 AM
RXi Pharmaceuticals Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights "PR Newswire (US)" - 8/10/2017 7:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 8/9/2017 4:48:43 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2017 7:40:18 AM
RXi Pharmaceuticals Enters into Common Stock Purchase Agreement for Up to $15.0 Million "PR Newswire (US)" - 8/9/2017 7:05:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 8/9/2017 6:05:04 AM
RXi Pharmaceuticals Advances Immuno-Oncology Pipeline by Selecting Two sd-rxRNA Compounds for Preclinical Development and Sou... "PR Newswire (US)" - 8/8/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/3/2017 8:07:27 AM
RXi Pharmaceuticals Granted 180-Day Extension by Nasdaq Stock Market to Regain Compliance with Listing Requirements "PR Newswire (US)" - 8/3/2017 8:05:00 AM
RXi Pharmaceuticals to Webcast Second Quarter 2017 Financial Results on Thursday, August 10, 2017 "PR Newswire (US)" - 8/3/2017 7:05:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist